247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

Alkem Laboratories Limited IPO (Alkem Laboratories IPO) Details

Alkem Laboratories Limited is an Pharmaceutical based company, located in Mumbai, Alkem Laboratories Limited IPO size was 1349.61 Cr. and was issued at 1050.00 per share. The share of Alkem Laboratories Limited were listed at 1381.45 per share and are currently trading at 5201.50 per share.

Type :
Sub Sector : Development Manufacture And Sale Of Pharmaceutical And Neutraceutical Products
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
5318.00 Cr.

PAT :
877.10 Cr.

Pricing Report

Issue Price :
1050.00

Listing Price :
1381.45

Current Market Price :
5201.50

Issue Price vs CMP :
4151.5 (395.38%)

listing Price vs CMP :
3820.05 (276.52%)

Performance Report (CAGR* wise)

CAGR : 19.26
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Alkem Laboratories

Company Information
Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. In fiscal year 2015, it was the fifth-largest pharmaceutical company in India in terms of domestic sales (Source: IMS SSA MAT March 2015). Additionally, it had the largest number of brands (five) in the top 50 brands of the Indian pharmaceutical industry for fiscal year 2015, based on domestic sales, alongside another leading pharmaceutical company (Source: IMS SSA MAT March 2015).

Established in 1973, the company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which are marketed in India and 55 countries internationally, with a primary focus on the United States. It has experienced strong growth under
Show More
Object of Issue
  • To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
  • For the sale of Equity Shares by the Selling Shareholders

Alkem Laboratories MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Dec, 2015
IPO Size :
1349.61 Cr.
IPO Subscription :
44.29 X     
PE Multiple :
28.00
Merchant Banker :
Axis Capital Limited
IPO Registrar:
Link Intime India Private Limited

Thinking of
Listing Your Business through
SME IPO?

We can Help!

Contact Us Today

See Other MainBoard IPOs in Mumbai

Abans Holdings Limited

  financial service arm of the well-diversified Abans group

  Mumbai



Advanced Enzyme Technologies Limited

  research and development manufacturing and marketing of healthcare products

  Mumbai


Peer Companies Of This Sector

FAQs

Alkem Laboratories operates in Pharmaceutical and Development Manufacture And Sale Of Pharmaceutical And Neutraceutical Products. The Issue is listed on MainBoard in Dec, 2015. Alkem Laboratories IPO size was 1349.61 Cr. with Issue price of 1050.00 .

Merchant Banker(s) of Alkem Laboratories IPO: Axis Capital Limited , Edelweiss Financial Services Limited , J.P. Morgan India Private Limited , Nomura Financial Advisory And Securities (India) Private Limited

Alkem Laboratories IPO subscription was 44.29 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Alkem Laboratories IPO listed at a listing price of 1381.45 against the offer price of 1050.00.

The current market price of Alkem Laboratories is 5201.50.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency